A stoma is an opening in your belly's wall that a surgeon makes in order for waste to leave your body if you can't have a bowel movement through your rectum. You might get one if you have ...

A woman is documenting her experiencing living with a stoma bag – including shopping for a wedding dress – because she wants to "normalise it and break the stigma". Poppy Williams, 27, from ...

Among at-risk patients undergoing elective coronary angiography (CAG) or PCI, delayed remote ischemic preconditioning (RIPC) reduces the incidence of contrast-associated acute kidney injury (CA-AKI) ...

Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...

Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the ...

Please provide your email address to receive an email when new articles are posted on . TNKase is the first stroke treatment approved by the FDA in almost 30 years, the manufacturer said.

Identifying an acute myocardial infarction on the 12-lead ECG is the most important thing you can learn in ECG interpretation. Time is muscle when treating heart attacks. Missing a ST segment ...

The US Food and Drug Administration has approved the thrombolytic tenecteplase for the treatment of patients with acute ischemic stroke, manufacturer Genentech announced today. The approval is based ...

Mini stroke, also known as a transient ischemic attack (TIA) is a short period of symptoms that are similar to that of a stroke. It is like a temporary stroke wherein there's a temporary lack of ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...